Director Site Training & Onboarding jobs in United States
cer-icon
Apply on Employer Site
company-logo

Regeneron · 14 hours ago

Director Site Training & Onboarding

Regeneron is seeking a Director Site Training & Onboarding to lead the technical GxP training program for IOPS. This role involves defining training strategies, managing the Learning Management System, and ensuring compliance with GxP regulations, while also overseeing employee onboarding and driving operational excellence through effective training programs.

BiopharmaBiotechnologyPharmaceutical
check
Comp. & Benefits

Responsibilities

Developing, managing, and delivering technical training programs and procedures
Overseeing and maintaining the employee onboarding program
Organizing GxP learning plans by role and ensuring compliance with applicable regulations
Counseling managers and employees to identify and address learning requirements through tailored development programs
Being responsible for all aspects of the LMS, including strategic guidance and system enhancements
Defining and facilitating contracts with training vendors
Analyzing the cGMP regulatory landscape and adapting systems and processes accordingly

Qualification

GxP training programLearning Management System (LMS)GMP complianceEmployee onboardingTraining strategy developmentRelationship managementContinuous improvementCross-functional teamwork

Required

BA/BS in a related field
At least 10 years of relevant experience in the pharmaceutical or related industry or equivalent combination of education and experience

Benefits

Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)

Company

Regeneron

company-logo
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.

Funding

Current Stage
Public Company
Total Funding
$15.93M
Key Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M

Leadership Team

leader-logo
Aris Baras
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
linkedin
leader-logo
Bari Kowal
Senior Vice President, Head Development Operations & Portfolio Management
linkedin
Company data provided by crunchbase